CSE:EATS - Post Discussion
Post by
ProfPennyPinch on Mar 30, 2021 1:44pm
$EATS Portfolio Company Signs Agreement with JSBiosciences
An Eat Beyond portfolio company, TurtleTree, signed an agreement to collaborate with JSBiosciences to create basal media at a commercial scale. JSBiosciences is a leading cell culture media supplier and will help TurtleTree expand operations effectively. With the global infant nutrition market estimated to reach $100B+ by 2026, TurtleTree is aiming to bridge the gap between formula and natural milk through its cell-based biotechnology. Lots of potential for the company as it is still a relatively young startup.
[https://ca.finance.yahoo.com/news/eat-beyond-portfolio-company-turtletree-130000756.html](https://ca.finance.yahoo.com/news/eat-beyond-portfolio-company-turtletree-130000756.html)
The $EATS portfolio continues to grow as they add more companies and the companies already within the portfolio begin to generate more revenue and funding. $EATS is up 4.4% today and is still a very small company with a market cap of only $36M. The plant-based food industry is set to grow exponentially this decade and $EATS is making strategic positioning themselves in order to profit as much as possible. I'm a shareholder in the company and over the longterm, I believe that $EATS will become a major player in the industry through their investments.
(CSE: EATS) (OTC: EATBF)
Be the first to comment on this post